As previously documented, CAFs modified the TME primarily through the continuous secretion of inflammatory cytokines essential for tumor proliferation, migration, invasion, metastasis and, resistance to treatment (e.g., vascular endothelial growth factor [VEGF] and HGF) [39–41]. The gene discussed is VEGFA; the disease is neoplasm.